Establishing an Integrative Oncology Service: Essential Aspects of Program Development
- PMID: 38358637
- DOI: 10.1007/s11912-024-01504-x
Establishing an Integrative Oncology Service: Essential Aspects of Program Development
Abstract
Purpose of review: Over the last 2 decades, integrative oncology (IO) has seen exponential growth within cancer care. It aims to combine evidence-based complementary therapies with conventional treatments to improve the well-being and quality of life for individuals dealing with cancer. The proliferation of integrative medicine programs in major cancer centers globally reflects varying approaches shaped by cultural, demographic, and resource-based factors.
Recent findings: Drawing upon the expertise of leaders in IO from the Society for Integrative Oncology (SIO) Clinical Practice Committee, this manuscript serves as a practical guide for establishing an IO practice. Collating insights from diverse professionals, including oncologists, integrative oncologists, supportive care physicians, researchers, and clinicians, the paper aims to provide a comprehensive roadmap for initiating and advancing IO services. The primary objective is to bridge the gap between conventional cancer care and complementary therapies, fostering a patient-centric approach to address the multifaceted challenges encountered by individuals with cancer. This paper delineates several key sections elucidating different aspects of IO practice. It delves into the core components necessary for an IO service's foundation, outlines the initial medical consultation process, and presents crucial tools essential for successful consultations. By consolidating insights and expertise, this manuscript seeks to facilitate the integration of IO into mainstream cancer care, ultimately enhancing patient outcomes and experiences.
Keywords: Cancer care; Complementary medicine; Integrative oncology; Patient-centered care; Practice guidelines; Supportive care.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Integrative Medicine for Ovarian Cancer.Curr Oncol Rep. 2023 Jun;25(6):559-568. doi: 10.1007/s11912-023-01359-8. Epub 2023 Mar 20. Curr Oncol Rep. 2023. PMID: 36939963 Review.
-
Integrative oncology and complementary medicine cancer services in Australia: findings from a national cross-sectional survey.BMC Complement Altern Med. 2018 Oct 29;18(1):289. doi: 10.1186/s12906-018-2357-8. BMC Complement Altern Med. 2018. PMID: 30373631 Free PMC article.
-
Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer.Support Care Cancer. 2021 Jul;29(7):4055-4064. doi: 10.1007/s00520-020-05961-5. Epub 2021 Jan 6. Support Care Cancer. 2021. PMID: 33404816
-
Integrative Oncology in Supportive Cancer Care in Israel.Integr Cancer Ther. 2018 Sep;17(3):697-706. doi: 10.1177/1534735418764839. Epub 2018 Apr 2. Integr Cancer Ther. 2018. PMID: 29607685 Free PMC article.
-
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review.Curr Oncol Rep. 2024 Jun;26(6):714-734. doi: 10.1007/s11912-024-01538-1. Epub 2024 May 11. Curr Oncol Rep. 2024. PMID: 38733465 Free PMC article. Review.
Cited by
-
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs.In Vivo. 2025 Mar-Apr;39(2):1000-1008. doi: 10.21873/invivo.13905. In Vivo. 2025. PMID: 40010972 Free PMC article.
-
Integrative medicine in oncology: redefining the standard of care.Nat Rev Cancer. 2024 Nov;24(11):739-740. doi: 10.1038/s41568-024-00735-1. Nat Rev Cancer. 2024. PMID: 39152264 No abstract available.
-
A Review of Anticancer Potential of Conferone, Diversin and Ferutinin; Which One is Stronger for Cancer Therapy?Anticancer Agents Med Chem. 2025;25(6):378-387. doi: 10.2174/0118715206328175241022081832. Anticancer Agents Med Chem. 2025. PMID: 39482921 Review.
-
Holistic Spiritual Care Practices, Competencies, and Needs in Cancer Treatment in Sub-Saharan Africa: A Scoping Review.J Relig Health. 2025 Jul 3. doi: 10.1007/s10943-025-02376-6. Online ahead of print. J Relig Health. 2025. PMID: 40608187
-
Phase-specific and laser-modulated polydopamine-chlorella-curdlan hydrogels: pioneering a melanoma integrative therapy.Theranostics. 2025 Jun 23;15(15):7627-7652. doi: 10.7150/thno.113417. eCollection 2025. Theranostics. 2025. PMID: 40756368 Free PMC article.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- Witt CM, Balneaves LG, Cardoso MJ, Cohen L, Greenlee H, Johnstone P, et al. A comprehensive definition for integrative oncology. J Natl Cancer Inst Monogr. 2017;2017(52):lgx012. https://doi.org/10.1093/jncimonographs/lgx012 .
-
- Seely DM, Weeks LC, Young S. A systematic review of integrative oncology programs. Curr Oncol. 2012;19(6):e436–61. https://doi.org/10.3747/co.19.1182 . - DOI - PubMed - PMC
-
- Rossi E, Vita A, Baccetti S, Stefano MD, Voller F, Zanobini A. Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe. Support Care Cancer. 2015;23(6):1795–806. https://doi.org/10.1007/s00520-014-2517-4 . - DOI - PubMed
-
- Mao JJ, Pillai GG, Andrade CJ, Ligibel JA, Basu P, Cohen L, et al. Integrative oncology: addressing the global challenges of cancer prevention and treatment. CA Cancer J Clin. 2022;72(2):144–64. https://doi.org/10.3322/caac.21706 . - DOI - PubMed
-
- Weeks L, Seely D, DeGrasse C, Verma S, Boon H, Verhoef M, et al. Developing an operational model for an integrative oncology program: a qualitative descriptive feasibility study. Support Care Cancer. 2014;22(3):731–9. https://doi.org/10.1007/s00520-013-2028-8 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous